1. Home
  2. BCYC vs BUI Comparison

BCYC vs BUI Comparison

Compare BCYC & BUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • BUI
  • Stock Information
  • Founded
  • BCYC 2009
  • BUI 2011
  • Country
  • BCYC United Kingdom
  • BUI United States
  • Employees
  • BCYC N/A
  • BUI N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • BUI Trusts Except Educational Religious and Charitable
  • Sector
  • BCYC Health Care
  • BUI Finance
  • Exchange
  • BCYC Nasdaq
  • BUI Nasdaq
  • Market Cap
  • BCYC 565.5M
  • BUI 600.6M
  • IPO Year
  • BCYC 2019
  • BUI N/A
  • Fundamental
  • Price
  • BCYC $8.76
  • BUI $26.58
  • Analyst Decision
  • BCYC Buy
  • BUI
  • Analyst Count
  • BCYC 11
  • BUI 0
  • Target Price
  • BCYC $22.91
  • BUI N/A
  • AVG Volume (30 Days)
  • BCYC 284.7K
  • BUI 59.8K
  • Earning Date
  • BCYC 10-31-2025
  • BUI 01-01-0001
  • Dividend Yield
  • BCYC N/A
  • BUI 6.79%
  • EPS Growth
  • BCYC N/A
  • BUI N/A
  • EPS
  • BCYC N/A
  • BUI 2.75
  • Revenue
  • BCYC $19,281,000.00
  • BUI N/A
  • Revenue This Year
  • BCYC N/A
  • BUI N/A
  • Revenue Next Year
  • BCYC N/A
  • BUI N/A
  • P/E Ratio
  • BCYC N/A
  • BUI $7.77
  • Revenue Growth
  • BCYC N/A
  • BUI N/A
  • 52 Week Low
  • BCYC $6.10
  • BUI $18.73
  • 52 Week High
  • BCYC $25.39
  • BUI $24.22
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 56.40
  • BUI 48.27
  • Support Level
  • BCYC $7.65
  • BUI $26.31
  • Resistance Level
  • BCYC $8.75
  • BUI $26.77
  • Average True Range (ATR)
  • BCYC 0.45
  • BUI 0.37
  • MACD
  • BCYC -0.03
  • BUI -0.02
  • Stochastic Oscillator
  • BCYC 55.56
  • BUI 20.51

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About BUI BlackRock Utility Infrastructure & Power Opportunities Trust

BlackRock Utility Infrastructure & Power Opportunities Trust is a closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by companies that are engaged in the Utilities, Infrastructure and Power Opportunities business segments anywhere in the world and by employing of writing (selling) call and put options.

Share on Social Networks: